Nicole J.
- Country
- The Netherlands
- Department
- 3401: Medical Oncology
Research Overview
- Safety, Dose-Finding, and Pharmacodynamic Study of BAY 3389934 in Patients with Sepsis-Associated Coagulopathy
- Evaluation of AZD5863 and Tocilizumab in Advanced or Metastatic Solid Tumors: A Phase I/II Dose Escalation and Expansion Study
- Pharmacokinetic Analysis of Capecitabine and Oxaliplatin in CES1 Variant Carriers with Advanced Gastrointestinal Carcinoma
Data & Insights
Has run more than one trial at 56 of 174 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating advanced gastrointestinal carcinomas, with particular attention to capecitabine-based therapies and their pharmacological responses in patients with specific genetic variations.
- Gastric Cancer
- Colorectal Cancer
- Biliary Tract Cancer
Expertise extends to managing hand-foot syndrome and personalized treatment approaches based on genetic markers.
Advanced Solid Tumors
Focuses on innovative treatments for metastatic solid tumors, including novel cell therapies and targeted therapeutic approaches involving CLDN6 and CLDN18.2 expression.
- Pancreatic Ductal Adenocarcinoma
- Hepatocellular Carcinoma
- Esophageal and Gastroesophageal Junction Cancers
Specializes in combination therapy approaches for advanced-stage cancers.
Gynecologic Oncology
Dedicated to treating gynecological tumors with expertise in managing endometrial, ovarian, and cervical cancers through innovative therapeutic strategies.
- Endometrial Cancer
- Ovarian Cancer
- Cervical Cancer
Experience in implementing targeted therapies and immunotherapy approaches for gynecologic malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.